4.7 Article

Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy

期刊

JOURNAL OF CLINICAL MEDICINE
卷 10, 期 17, 页码 -

出版社

MDPI
DOI: 10.3390/jcm10173761

关键词

cervical cancer; early-stage cervical cancer; LACC trial; minimally invasive surgery; open radical hysterectomy

资金

  1. Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds

向作者/读者索取更多资源

This study systematically assessed disease-free survival, overall survival, and morbidity rates after surgical treatment for early-stage cervical cancer and discussed the impact of the LACC trial on clinical routine. The LACC trial found higher disease progression and recurrence rates with minimally invasive surgery compared to open radical hysterectomy, but there were conflicting results and opinions from other studies. More randomized controlled trials are needed to determine the most suitable treatment for early-stage cervical cancer.
Objective: The aim of the study was to perform a systematic assessment of disease-free survival (DFS), overall survival, and morbidity rates after open radical hysterectomy (ORH) and minimally invasive surgery (MIS) for early-stage cervical cancer and discuss with experts the consequences of the LACC trial (published by Ramirez et al. in 2018) on clinical routine. Methods: A total of 5428 records were retrieved. After exclusion based on text screening, four records were identified for inclusion. Five experts from three independent large-volume medical centers in Europe were interviewed for their interpretation of the LACC trial. Results: The LACC trial showed a significantly higher risk of disease progression with MIS compared to ORH (HR 3.74, 95% CI 1.63 to 8.58). This was not seen in one epidemiological study and was contradicted by one prospective cohort study reported by Greggi et al. A systematic review by Zhang et al. mentioned a similar DFS for robot-assisted radical hysterectomy (RRH) and LRH. Recurrence rates were significantly higher with MIS compared to ORH in the LACC trial (HR 4.26, 95% CI 1.44 to 12.60). In contrast, four studies presented by Greggi reported no significant difference in recurrence rates between LRH/RRH and ORH, which concurred with the systematic reviews of Zhang and Zhao. The experts mentioned various limitations of the LACC trial and stated that clinicians were obliged to provide patients with detailed information and ensure a shared decision-making process. Conclusions: The surgical treatment of early-stage cervical cancer remains a debated issue. More randomized controlled trials (RCT) will be needed to establish the most suitable treatment for this condition.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据